| CEO Name | Dilip Shanghvi |
| Nationality | India |
| Net Worth Estimation | $23 billion |
Dilip Shanghvi, founder and current CEO of Sun Pharmaceutical Industries Ltd., has amassed an estimated net worth of around $23 billion due to his significant equity stake and successful expansion of Sun Pharma into one of the world's largest generic drug manufacturers. His wealth is directly tied to the company's market capitalization, global revenue growth, and success in strategic acquisitions.
Dilip Shanghvi's estimated net worth of $23,000,000,000 far surpasses the typical CEO net worth in the healthcare sector, which ranges from $10 million to $90 million. His net worth is approximately 25,556% higher than the maximum estimated net worth in this business category.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Dilip Shanghvi Performance in Sun Pharmaceutical Industries Ltd.
Dilip Shanghvi, CEO of Sun Pharmaceutical Industries Ltd., demonstrates strategic leadership and decisive decision-making that have driven the company's global expansion and innovation. His focus on cost-effective R&D and acquisitions has significantly enhanced operational performance and market share. Under his tenure, Sun Pharma has grown into one of India's largest pharmaceutical companies, solidifying its position as a global industry leader.
Latest News
Sun Pharmaceutical Industries Ltd. appoints Richard Ascroft as North America CEO
Richard Ascroft, formerly with Takeda Pharmaceuticals and Eli Lilly, became CEO of Sun Pharma North America in June 2025, succeeding Abhay Gandhi. He will lead the expansion of Sun Pharma's portfolio in the U.S. and Canada, driving growth with upcoming launches for alopecia areata and squamous cell carcinoma treatments.
Source: http://njbiz.com/sun-pharma-names-ascroft-north-america-ceo/